9H-pyrido[3,4-b]indole-3-carbonitrile

ID: ALA5266558

Max Phase: Preclinical

Molecular Formula: C12H7N3

Molecular Weight: 193.21

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1cc2c(cn1)[nH]c1ccccc12

Standard InChI:  InChI=1S/C12H7N3/c13-6-8-5-10-9-3-1-2-4-11(9)15-12(10)7-14-8/h1-5,7,15H

Standard InChI Key:  RYLDZJANGRBUGW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
   -1.3792   -0.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0938   -0.6282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6673   -0.6278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6673   -1.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3774   -1.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0938   -1.4567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1155   -1.6989    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1368   -0.3776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6075   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4669    0.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2686    0.4355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7385   -0.2137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4124   -0.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6812    1.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0938    1.8648    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  2  6  1  0
  4  7  1  0
  3  8  1  0
  9  8  2  0
  9  7  1  0
  8 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  9 13  1  0
 11 14  1  0
 14 15  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5266558

    ---

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; anion channel (986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 193.21Molecular Weight (Monoisotopic): 193.0640AlogP: 2.59#Rotatable Bonds:
Polar Surface Area: 52.47Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.63CX Basic pKa: 0.91CX LogP: 2.12CX LogD: 2.12
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.60Np Likeness Score: -0.38

References

1. Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R..  (2021)  β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.,  64  (3.0): [PMID:33528252] [10.1021/acs.jmedchem.0c01887]

Source